Next Century Growth Investors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.1M Buy
200,672
+173,705
+644% +$18.9M 1.6% 20
2026
Q1
$2.49M Buy
26,967
+8,483
+46% +$852K 0.18% 103
2025
Q4
$1.89M Buy
+18,484
New +$1.65M 0.13% 117
2020
Q4
Sell
-20,167
Closed -$2.25M 134
2020
Q3
$2.25M Sell
20,167
-1,122
-5% -$103K 0.23% 102
2020
Q2
$1.73M Sell
21,289
-82
-0.4% -$6.61K 0.2% 106
2020
Q1
$1.49M Buy
21,371
+3
+0% +$230 0.24% 100
2019
Q4
$1.67M Sell
21,368
-346
-2% -$24.9K 0.22% 104
2019
Q3
$1.39M Sell
21,714
-9,297
-30% -$819K 0.22% 100
2019
Q2
$2.68M Sell
31,011
-151
-0.5% -$11.5K 0.33% 86
2019
Q1
$2.39M Sell
31,162
-33,338
-52% -$1.85M 0.32% 93
2018
Q4
$2.42M Buy
+64,500
New +$2.38M 0.34% 95

Other funds holding GH

Next Century Growth Investors's GH Position: Q2 2026 in Review

Next Century Growth Investors increased its Guardant Health (GH) stake by 644% in Q2 2026, buying an estimated $18.9M and bringing the position to 200,672 shares worth $30.1M. The position accounts for 1.6% of the portfolio, ranked #20.

Next Century Growth Investors first reported a position in GH in Q4 2018 and has held it in 11 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Next Century Growth Investors held 200,672 shares of Guardant Health worth $30.1M as of Q2 2026.
  • Next Century Growth Investors bought 173,705 Guardant Health shares in Q2 2026, an estimated $18.9M.
  • Guardant Health made up 1.6% of Next Century Growth Investors's portfolio in Q2 2026, its #20 holding.
  • Next Century Growth Investors first reported a position in Guardant Health in Q4 2018 and has held it in 11 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Next Century Growth Investors's 13F filing for Q2 2026, filed 14 Aug 2026.